Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared. Healthy HBV-naive adults were randomized to receive HBs adjuvanted with alum or Adjuvant Systems AS01B, AS01E, AS03A or AS04 at Days 0 and 30. Different frequencies of HBs-specific CD4+ T cells 14 days post dose 2 but similar polyfunctionality profiles were induced by the different adjuvants with frequencies significantly higher in the AS01B and AS01E groups than in the other groups. Antibody concentrations 30 days post-dose 2 were significantly higher in AS01B, AS01E and AS03A than in other groups. Limited correlations were observed between HBs-specific CD4+ T cell and antibody responses. Injection site pain was the most common solicited l...
Adjuvants like AS01B increase the immunogenicity of vaccines and generally cause increased transient...
A randomised, double-blind study assessing the potential of four adjuvants in combination with recom...
Developing efficient adjuvants for human vaccines, in order to elicit broad and sustained immune res...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
AbstractImmunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were ...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
Background Adjuvants like AS01B increase the immunogenicity of vaccines and generally cause increase...
To elucidate the role of innate responses in vaccine immunogenicity, we compared early responses to ...
To elucidate the role of innate responses in vaccine immunogenicity, we compared early responses to ...
Differences in innate immune ‘imprinting’ between vaccine adjuvants may mediate dissimilar effects o...
A randomised, double-blind study assessing the potential of four adjuvants in combination with recom...
The reactogenicity and safety of an experimental hepatitis B (HB) vaccine containing adjuvant system...
An open-label randomized study was undertaken to compare a 2-dose regimen (Months 0 and 6) of hepati...
Adjuvants like AS01B increase the immunogenicity of vaccines and generally cause increased transient...
A randomised, double-blind study assessing the potential of four adjuvants in combination with recom...
Developing efficient adjuvants for human vaccines, in order to elicit broad and sustained immune res...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
AbstractImmunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were ...
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared...
Background Adjuvants like AS01B increase the immunogenicity of vaccines and generally cause increase...
To elucidate the role of innate responses in vaccine immunogenicity, we compared early responses to ...
To elucidate the role of innate responses in vaccine immunogenicity, we compared early responses to ...
Differences in innate immune ‘imprinting’ between vaccine adjuvants may mediate dissimilar effects o...
A randomised, double-blind study assessing the potential of four adjuvants in combination with recom...
The reactogenicity and safety of an experimental hepatitis B (HB) vaccine containing adjuvant system...
An open-label randomized study was undertaken to compare a 2-dose regimen (Months 0 and 6) of hepati...
Adjuvants like AS01B increase the immunogenicity of vaccines and generally cause increased transient...
A randomised, double-blind study assessing the potential of four adjuvants in combination with recom...
Developing efficient adjuvants for human vaccines, in order to elicit broad and sustained immune res...